Phase II study of rituximab and gemcitabine in patients with relapsed or refractory diffuse large B-cell lymphoma: Hoosier Oncology Group LYM03-64.
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2014
At a glance
- Drugs Gemcitabine; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 08 Nov 2007 Status changed from in progress to discontinued (due to lack of response at the first efficacy analysis).
- 27 Nov 2005 New trial record.